Loading
Pharmanutra Pharmanutra S.p.A.: le Novita SUI Mercati Esteri Stock: price and insider trades · Italy
Pharmanutra Pharmanutra S.p.A.: le Novita SUI Mercati Esteri: what insiders have been doing
Only a handful of insider records exist for Pharmanutra Pharmanutra S.p.A.: le Novita SUI Mercati Esteri, too few to describe a trend. These figures are compiled from regulatory filings published by Consob. They describe what insiders did and are not a recommendation.
Insider Decl.
n/a
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 7,053 of 24,148 companies
61.9
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.6x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€82.20
Analyst consensus
3 analysts€76.00Target €81.33(-1%)€86.00
Income statement
Revenue€132.9M
Gross profit€102.9M77% margin
EBITDA€34.3M26% margin
Net income€20.0M15.1% margin
Valuation
PER (trailing)37.4x
PER (forward)26.8x
P/Book10.6x
Beta0.19
Balance sheet & cash
Market cap€787.1M
Total debt€20.5M
Free Cash Flow€16.4M
Debt / Equity26%
Profitability & ownership
ROE30.1%
ROA15.2%
% insiders65.0%
% institutions16.0%
Declarations0 total
No declarations found
0 of 0 declarations
About Pharmanutra Pharmanutra S.p.A.: le Novita SUI Mercati Esteri
PHARMANUTRA S.P.A. is an Italian company operating in the health and pharmaceutical sector. It focuses on innovation and expansion into foreign markets.
